P. Burton, A. Hansell, I. Fortier, T. Manolio, M. Khoury, J. Little, and P. Elliott. International journal of epidemiology, 38 (1):
263-73(February 2009)4935<m:linebreak></m:linebreak>GR: 075883/Wellcome Trust/United Kingdom; GR: G9806740/Medical Research Council/United Kingdom; JID: 7802871; CIN: Int J Epidemiol. 2009 Feb;38(1):274-5. PMID: 18984600; OID: NLM: PMC2639365; 2008/08/01 aheadofprint; 2008/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Epidemiologia genètica.
F. de Vries, C. de Vries, C. Cooper, B. Leufkens, and T. van Staa. International journal of epidemiology, 35 (5):
1301-8(October 2006)4268<m:linebreak></m:linebreak>PUBM: Print; JID: 7802871; 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); CIN: Int J Epidemiol. 2006 Oct;35(5):1308-9. PMID: 17053012; CIN: Int J Epidemiol. 2006 Oct;35(5):1310-1. PMID: 17053013; CIN: Int J Epidemiol. 2006 Oct;35(5):1312-3. PMID: 17053014; ppublish;<m:linebreak></m:linebreak>New-user designs; Mesures d'associació.
K. Sainani. PM & R : the journal of injury, function, and rehabilitation, 4 (3):
220-2(March 2012)6600<m:linebreak></m:linebreak>JID: 101491319; 2012/01/13 received; 2012/01/13 accepted; ppublish; Bon exemple amb la THS<m:linebreak></m:linebreak>Presentació de dades; Interpretació de resultats; Risc relatiu vs absolut; NNT; HRT; Introductori.
D. Lai, T. King, L. Moyé, and Q. Wei. Annals of epidemiology, 13 (3):
204-8(March 2003)3153<m:linebreak></m:linebreak>Sample size; Surrogate endpoints; Dades longitudinals.